← Leaderboards
Iris Z Jaffe
Tufts Medical Center
$20,757,672
Attributed
$28,187,021
Total exposure
9
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.9M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$28,187,021 · 9
By mechanism
R01$21,492,164 · 5
K12$6,047,657 · 2
K08$637,200 · 1
R13$10,000 · 1
Top collaborators
- Karen Freund12 shared
- Cheryl A London5 shared
- Lakshmidevi None Pulakat5 shared
- Michael A Hill4 shared
- Daniela Rotin1 shared
- Peter M Snyder1 shared
Most similar at Tufts Medical Center
Same institution · by research overlap
- Joachim H Ix$16,690,262
- Michael G Shlipak$18,418,069
- Patricia L Hibberd$21,584,178
- Orlando M Gutierrez$29,690,151
- Inga Peter$17,466,985
Others in their field
Top investigators on “In Vitro”
- David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Dennis R. Burton · Scripps Research Institute$79,204,175
Research focus
In VitroBlood VesselsCardiovascular DiseasesCardiovascular SystemPreventMineralocorticoid ReceptorBaseResponseResearch PersonnelInnovationMouse ModelMolecularIn VivoPharmaceutical PreparationsHypertensionMyocardial InfarctionHeart FailureAldosteroneCellsWomanProgramsSex DifferencesKnockout MiceBlood Pressure
Grant awards (55)
Smooth Muscle Mineralocorticoid Receptor in Obesity-Induced Vascular Stiffness$762,388
R01 · FY2025 · HL · contact PI
Tufts BIRCWH Program$642,489
K12 · FY2025 · AR
The Role of Vascular MR-Regulated Genes in Vascular Function and Disease$768,831
R01 · FY2024 · HL · contact PI
Novel strategies to understand, predict, and prevent vascular toxicity of targeted CML therapies$648,472
R01 · FY2024 · HL · contact PI
Tufts BIRCWH Program$642,489
K12 · FY2024 · AR
Supporting the Tufts BIRCWH Program with an Additional Scholar Position$327,390
K12 · FY2024 · AR
Tufts BIRCWH Program$829,854
K12 · FY2023 · HD
The Role of Vascular MR-Regulated Genes in Vascular Function and Disease$784,522
R01 · FY2023 · HL · contact PI
Novel strategies to understand, predict, and prevent vascular toxicity of targeted CML therapies$661,706
R01 · FY2023 · HL · contact PI
Credentialing a Cross-Species Platform to Investigate Cancer Therapy-Associated Cardiovascular Toxicity$597,582
R01 · FY2023 · CA · contact PI
Tufts BIRCWH Program$95,920
K12 · FY2023 · AR
The Role of Vascular MR-Regulated Genes in Vascular Function and Disease$784,522
R01 · FY2022 · HL · contact PI
Smooth Muscle Mineralocorticoid Receptor in Vascular Aging and Hypertension$762,573
R01 · FY2022 · HL · contact PI
Novel strategies to understand, predict, and prevent vascular toxicity of targeted CML therapies$655,590
R01 · FY2022 · HL · contact PI
Tufts BIRCWH Program$644,489
K12 · FY2022 · HD
Credentialing a Cross-Species Platform to Investigate Cancer Therapy-Associated Cardiovascular Toxicity$617,870
R01 · FY2022 · CA · contact PI
Transforming Training to Increase Diversity in the Tufts BIRCWH Program$189,365
K12 · FY2022 · HD
The Role of Vascular MR-Regulated Genes in Vascular Function and Disease$784,522
R01 · FY2021 · HL · contact PI
Smooth Muscle Mineralocorticoid Receptor in Vascular Aging and Hypertension$762,573
R01 · FY2021 · HL · contact PI
Novel strategies to understand, predict, and prevent vascular toxicity of targeted CML therapies$675,539
R01 · FY2021 · HL · contact PI
Credentialing a Cross-Species Platform to Investigate Cancer Therapy-Associated Cardiovascular Toxicity$614,697
R01 · FY2021 · CA · contact PI
Tufts BIRCWH Program$538,400
K12 · FY2021 · HD
Mechanisms for Sex Differences in CVD Pathology and Development of a Targeted Therapeutic$515,319
R01 · FY2021 · HL
Smooth Muscle Mineralocorticoid Receptor in Vascular Aging and Hypertension$762,573
R01 · FY2020 · HL · contact PI
Mechanisms for Sex Differences in CVD Pathology and Development of a Targeted Therapeutic$692,975
R01 · FY2020 · HL
Credentialing a Cross-Species Platform to Investigate Cancer Therapy-Associated Cardiovascular Toxicity$661,594
R01 · FY2020 · CA · contact PI
Tufts BIRCWH Program$538,400
K12 · FY2020 · HD
Smooth Muscle Mineralocorticoid Receptor in Vascular Aging and Hypertension$784,123
R01 · FY2019 · HL · contact PI
Credentialing a Cross-Species Platform to Investigate Cancer Therapy-Associated Cardiovascular Toxicity$644,071
R01 · FY2019 · CA · contact PI
Mechanisms for Sex Differences in CVD Pathology and Development of a Targeted Therapeutic$545,566
R01 · FY2019 · HL
Tufts BIRCWH Program$522,061
K12 · FY2019 · HD
Mechanisms for Sex Differences in CVD Pathology and Development of a Targeted Therapeutic$373,750
R01 · FY2019 · HL
9th Annual International Conference of Aldosterone and ENaC$10,000
R13 · FY2019 · DK
Tufts BIRCWH Program$538,400
K12 · FY2018 · HD
Mechanisms for Sex Differences in CVD Pathology and Development of a Targeted Therapeutic$462,442
R01 · FY2018 · HL
The Role of Vascular MR-Regulated Genes in Vascular Function and Disease$445,426
R01 · FY2018 · HL · contact PI
Smooth Muscle Mineralocorticoid Receptors in Vascular Aging and Hypertension$543,174
R01 · FY2017 · HL · contact PI
Tufts BIRCWH Program$538,400
K12 · FY2017 · HD
The Role of Vascular MR-Regulated Genes in Vascular Function and Disease$445,426
R01 · FY2017 · HL · contact PI
Smooth Muscle Mineralocorticoid Receptors in Vascular Aging and Hypertension$623,160
R01 · FY2016 · HL · contact PI
The Role of Vascular MR-Regulated Genes in Vascular Function and Disease$445,426
R01 · FY2016 · HL · contact PI
Smooth Muscle Mineralocorticoid Receptors in Vascular Aging and Hypertension$560,210
R01 · FY2015 · HL · contact PI
The Role of Vascular MR-Regulated Genes in Vascular Function and Disease$400,435
R01 · FY2015 · HL · contact PI
Smooth Muscle Mineralocorticoid Receptors in Vascular Aging and Hypertension$99,970
R01 · FY2015 · HL · contact PI
Smooth Muscle Mineralocorticoid Receptors in Vascular Aging and Hypertension$614,476
R01 · FY2014 · HL · contact PI
The Role of Vascular MR-Regulated Genes in Vascular Function and Disease$374,636
R01 · FY2013 · HL · contact PI
The Role of Vascular MR-Regulated Genes in Vascular Function and Disease$393,525
R01 · FY2012 · HL · contact PI
The Role of Vascular MR-Regulated Genes in Vascular Function and Disease$397,500
R01 · FY2011 · HL · contact PI
The Role of Vascular MR-Regulated Genes in Vascular Function and Disease$412,500
R01 · FY2010 · HL · contact PI
The Role of Vascular MR-Regulated Genes in Vascular Function and Disease$412,500
R01 · FY2009 · HL · contact PI
Mineralocorticoid Receptors in Cardiovascular Biology$127,440
K08 · FY2009 · HL · contact PI
Mineralocorticoid Receptors in Cardiovascular Biology$127,440
K08 · FY2008 · HL · contact PI
Mineralocorticoid Receptors in Cardiovascular Biology$127,440
K08 · FY2007 · HL · contact PI
Mineralocorticoid Receptors in Cardiovascular Biology$127,440
K08 · FY2006 · HL · contact PI
Mineralocorticoid Receptors in Cardiovascular Biology$127,440
K08 · FY2005 · HL